Sbi Securities Co., Ltd. Annovis Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 403 shares of ANVS stock, worth $1,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
403Holding current value
$1,217% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANVS
# of Institutions
49Shares Held
1.25MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$1.15 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$310,1290.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$304,1410.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.1KShares$299,3240.0% of portfolio
-
Merit Financial Group, LLC98.5KShares$297,5180.01% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $24.7M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...